Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata

Experimental Neurology

Volumn 144, Issue 1, 1997, Pages 183-192

  Hardman, C D ^a   Halliday, G M ^a   McRitchie, D A ^a   Cartwright, H R ^a   Morris, J G L ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PARVALBUMIN; TAU PROTEIN;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUBSTANTIA NIGRA;

EID: 0031106007     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6415     Document Type: Article

References (46)

1. 1. Albert, M., R. Feldman, and A. Willis. 1974. The "subcortical dementia" of progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 37: 121-130.
2. 2. Berardelli, A. 1995. Symptomatic or secondary basal ganglia diseases and tardive dyskinesias. Curr. Opin. Neurol. 8: 320-322.
3. 3. Bergman, H., T. Wichmann, and M. DeLong. 1990. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436-1438.
4. 4. Bolam, P., and Y. Smith. 1991. Characterization of the synaptic inputs to dopaminergic neurons in the rat sustantia nigra. Pages 119-131 in G. Bernardi, M. Carpenter, G. Di Chiara, M. Morelli, and P. Stanzione, Eds., Basal Ganglia III. Plenum, New York.
5. 5. Cardoso, F., and J. Jankovic. 1994. Progressive supranuclear palsy. Pages 769-786 in D. Calne, ed., Neurodegenerative Diseases. Saunders, Philadelphia.
6. 6. Celio, M. 1990. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35: 375-475.
7. 7. Chard, P., D. Bleakman, S. Christakos, C. Fullmer, and R. Miller. 1993. Calcium buffering properties of calbindin D28K and parvalbumin in rat sensory neurons. J. Physiol. 472: 344-357.
8. 8. Chin, S-M., and J. Goldman. 1996. Glial inclusions in CNS degenerative diseases. J. Neuropathol. Exp. Neurol. 55: 499-508.
9. 9. Collins, S., J. Ahlskog, J. Parisi, and D. Maraganore. 1995. Progressive supranuclear palsy: Neuropathologically based diagnostic clinical criteria. J. Neurol. Neurosurg. Psychiatry 58: 167-173.
10. 10. Cullen, K., G. Halliday, H. Cartwright, and J. Kril. 1996. Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads. Neurodegeneration 5: 177-187.
11. 11. Daniel, S., V. de Bruin, and A. Lees. 1995. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): A reappraisal. Brain 118: 759-770.
12. 12. Feany, M., L. Mattiace, and D. Dickson. 1996. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J. Neuropathol. Exp. Neurol. 55: 53-67.
13. 13. Fearnley, J., and A. Lees. 1991. Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 114: 2283-2301.
14. 14. Fearnley, J., and A. Lees. 1994. Pathology of Parkinson's disease. Pages 545-554 in D. Calne, ed., Neurodegenerative Diseases. Saunders, Philadelphia.
15. 15. Francois, C., G. Percheron, and J. Yelnik. 1984. Localization of nigrostriatal, nigrothalamic and nigrotectal neurons in ventricular coordinates in macaques. Neuroscience 13: 61-76.
16. 16. Goetz, C., M. DeLong, R. Penn, and R. Bakay. 1993. Neurosurgical horizons in Parkinson's disease. Neurology 43: 1-7.
17. 17. Haber, S., E. Lynd-Balta, and S. Mitchell. 1993. The organization of the descending ventral pallidal projections in the monkey. J. Comp. Neurol. 329: 111-128.
18. 18. Halliday, G., D. McRitchie, H. Cartwright, R. Pamphlett, M. Hely and J. Morris. 1996. Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. J. Clin. Neurosci. 3: 52-60.
19. 19. Hardman, C., D. McRitchie, G. Halliday, H. Cartwright, and J. Morris. 1996. Substantia nigra pars reticulata neurons in Parkinson's disease. Neurodegeneration 5: 49-55.
20. 20. Hauw, J-J., S. Daniel, D. Dickson, D. Horoupian, K. Jellinger, P. Lantos, A. McKee, M. Tabaton, and I. Litvan. 1994. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015-2019.
21. 21. Hauw, J-J., M. Verny, P. Delaere, P. Cervera, Y. He, and C. Duyckaerts. 1990. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and ageing. Neurosci. Lett. 119: 182-186.
22. 22. Ilinsky, I., M. Jouandet, and P. Goldman-Rakic. 1985. Organization of the nigrothalamocortical system in the rhesus monkey. J. Comp. Neurol. 236: 315-330.
23. 23. Jankovic, J., D. Friedman, F. Pirozzolo, and J. McCrary. 1990. Progressive supranuclear palsy: Motor, neurobehavioural, and neuro-ophthalmic findings. Pages 293-303 in A. Korczyn, E. Melamed, and M. Youdim, Eds., Parkinson's Disease: Anatomy, Pathology, and Therapy, Volume 53 of Advances in Neurology. Raven Press, New York.
24. 24. Kawaguchi, Y., H. Katsumaru, T. Kosaka, C. W. Heizmann, and K. Kama. 1987. Fast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin. Brain Res. 416: 369-374.
25. 25. Kawai, K., T. J. Nawak, and I. Klatzo. 1995. Loss of parvalbumin immunoreactivity defines selectively vulnerable thalamic reticular nucleus neurons following cardiac arrest in the rat. Acta Neuropathol. 89: 262-269.
26. 26. Lauterbach E., T. Spears, M. Prewett, S. Price, J. Jackson, and A. Kirsh. 1994. Neuropsychiatrie disorders, myoclonus, and dystonia in calcification of basal ganglia pathways. Biol. Psychiat. 35: 335-344.
27. 27. Lee, M., and C. Marsden. 1994. Neurological sequelae following carbon monoxide poisoning: Clinical course and outcome according to the clinical types and brain computed tomography scan findings. Mov. Disord. 9: 550-558.
28. 28. Litvan, I., J. Hauw, J. Bartko, P. Lantos, S. Daniel, D. Horoupian, A. McKee, D. Dickson, C. Bancher, M. Tabaton, K. Jellinger, and D. Anderson. 1996. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J. Neuropathol. Exp. Neurol. 55: 97-105.
29. 29. Maher, E., E. Smith, and A. Lees. 1985. Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J. Neurol. Neurosurg. Psychiatry 48: 1234-1239.
30. 30. McRitchie, D., G. Halliday, and H. Cartwright. 1995. Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human. Neuroscience 68: 539-551.
31. 31. McRitchie, D., C. Hardman, and G. Halliday. 1996. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J. Comp. Neurol. 364: 121-150.
32. 32. Olanow, C., P. Good, H. Shinotoh, K. Hewitt, F. Vingerhoets, B. Snow, M. Beal, D. Calne, and D. Perl. 1996. Manganese intoxication in the rhesus monkey. Neurology 46: 492-498.
33. 33. Oyanagi, K., H. Takahashi, K. Wakabayashi, and F. Ikuta. 1988. Selective decrease of large neurons in the neostriatum in progressive supranuclear palsy. Brain Res. 458: 218-223.
34. 34. Parent, A., C. Bouchard, and Y. Smith. 1984. The striatopallidal and striatonigral projections: Two distinct fibre systems in primate. Brain Res. 303: 385-390.
35. 35. Percheron, G., M. Filion, L. Tremblay G. Fenelon, C. Francois, and J. Yelnik. 1993. The role of the medial pallidum in the pathophysiology of akinesia in primates. Pages 84-87 in H. Narabayashi, T. Nagatsu, N. Yanagisawa, and Y. Mizuno, Eds.), Advances in Neurology, vol. 60. Raven Press, New York.
36. 36. Probst, A., D. Langui, C. Lautenschlager, J. Ulrich, J. Brion, and B. Anderton. 1988. Progressive supranuclear palsy: Extensive neuropil threads in addition to neurofibrillary tangles. Acta Neuropathol. 77: 61-68.
37. 37. Reid, M., M. Herrera-Marschitz, T. Hokfelt, N. Lindefors, H. Persson, and U. Ungerstedt. 1990. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: Evidence for direct regulatory mechanisms. Exp. Brain Res. 82: 293-303.
38. 38. Rinvik, E., and O. Ottersen. 1993. Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: An electron microscopic, immunogold analysis in the cat. J. Chem. Neuroanat. 6: 19-30.
39. 39. Smith, Y., L.-N. Harzrati, and A. Parent. 1990. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J. Comp. Neurol. 294: 306-323.
40. 40. Smith, Y., and A. Parent. 1988. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res. 453: 353-356.
41. 41. Smith, Y., A. Parent, P. Seguela, and L. Descarries. 1987. Distribution of GABA-immunoreactive neurons in the basal ganglia of the squirrel monkey (Saimiri sciureus). J. Comp. Neurol. 259: 50-64.
42. 42. Solbach, S., and M. Celio. 1991. Ontogeny of the calcium binding protein parvalbumin in the rat nervous system. Anat. Embryol. 184: 103-124.
43. 43. Steele, J., J. Richardson, and J. Olszewski. 1964. A heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol. 10: 333-359.
44. 44. Tokuno, H., M. Takada, Y Kondo, and N. Mizuno. 1993. Laminar organization of the substantia nigra pars reticulata in the macaque monkey, with special reference to the caudato-nigro-tectal link. Exp. Brain Res. 92: 545-548.
45. 45. Vila, M., M. Herrero, R. Levy, B. Faucheux, M. Ruberg, J. Guillens, M. Luquin, J. Guridi, F. Javoy-Agid, Y Agid, J. Obeso, and E. Hirsch. 1996. Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology 46: 802-809.
46. 46. Vila, M., R. Levy, M.-T. Herrero, B. Faucheux, J. Obeso, Y. Agid, and E. Hirsch. 1996. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study. Neuroscience 71: 903-912.